FDA Updates Warnings on All Stimulants for ADHD, Other Conditions
The FDA is updating warnings for stimulants prescribed for attention-deficit/hyperactivity disorder (ADHD) and other conditions, citing concerns about nonmedical use of the drugs. In a drug safety communication on Thursday, the agency said the boxed warning for the entire class of central nervous system stimulants would get standardized language to more clearly state the dangers …
FDA Updates Warnings on All Stimulants for ADHD, Other Conditions Read More »









